Comparison · NCT01002482-sae
CGAO-based Glucose Control vs Standard-Care Glucose Gontrol: serious adverse events
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. CGAO-based Glucose Control vs Standard-Care Glucose Gontrol: serious adverse events. Trial comparisons, record NCT01002482-sae. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01002482-sae
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.015 | 0.00971 | 0.023 | wilson | |
| Risk in group 2 | 0.00457 | 0.0021 | 0.00994 | wilson | |
| Risk difference, group 1 minus group 2 | 0.0104 | 0.00288 | 0.0188 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 3.27 | 1.32 | 8.13 | log | |
| Odds ratio, group 1 over group 2 | 3.31 | 1.32 | 8.26 | log | |
| Number needed to harm, for one more participant with a serious adverse event on CGAO-based Glucose Control than on Standard-Care Glucose Gontrol | 96.2 | 53.2 | 347 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | CGAO-based Glucose Control | Use of a Computerized Protocol fot Tight Glycemic Control named CGAO software in order to maintain Blood Glucose Levels between 4.4 and 6.1 mmol/l. | 20 | 1,336 | EG000 |
| Group 2 | Standard-Care Glucose Gontrol | Use of Standard-Care Methods for Glucose Control targeting Blood Glucose Levels inferior to 10 mmol/l. | 6 | 1,312 | EG001 |
Source ClinicalTrials.gov
Harm
- What it counts
- Total, serious adverse events
- Time frame
Source ClinicalTrials.gov
Trial
- Title
- Computerized Glucose Control in Critically Ill Patients
- NCT number
- NCT01002482
- Phases
- PHASE3
- Conditions
- Hyperglycemia, Critical Illness
- Interventions
- CGAO-based Glucose Control, Standard-Care Glucose Control
- Lead sponsor
- Centre Hospitalier of Chartres
- Results first posted
- 2013-12-03
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01002482?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01002482-sae